1. Medtech Insight

Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future

 
• By Reed Miller

Medtech Insight caught up again with iRhythm CEO Quentin Blackford about his vision for the company as it plans for the next five to ten years of expansion in the remote cardiac monitoring and arrhythmia diagnostics market.

Zio XT Patch Side View
iRhythm's Zio XT long-term remote cardiac monitoring patch • Source: iRhythm

After a tumultuous 2021 during which the company had four CEOs and faced significant reimbursement challenges in the US, iRhythm Technologies is ready to focus on its future and innovation in remote cardiac monitoring.

Over the past two years, the company has expended enormous effort and resources on improving the Medicare reimbursement rates for its Zio XT long-term continuous cardiac

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Patient Monitoring

More from Device Area